Duffy Sean P. 4
4 · Omada Health, Inc. · Filed Jun 26, 2026
Research Summary
AI-generated summary of this filing
Omada Health (OMDA) CEO Sean P. Duffy Sells 17,258 Shares
What Happened Sean P. Duffy, Chief Executive Officer of Omada Health (OMDA), disposed of a total of 17,258 shares in multiple open-market sales between June 24–26, 2026, generating approximately $342,116 in proceeds. The individual transactions reported were: 2,800 shares at $19.01 ($53,239); 300 shares at $19.00 ($5,701); 9,844 shares at $19.61 ($193,013); and 4,314 shares at $20.90 ($90,163). These were sales (disposals), not purchases — commonly routine insider selling rather than a purchase signal.
Key Details
- Transaction dates: 2026-06-24, 2026-06-25, and 2026-06-26. Filed with the SEC on 2026-06-26.
- Prices: reported per-trade averages above; two transactions were executed in multiple trades with reported weighted-average prices (price ranges noted in filing).
- Total shares sold: 17,258; total proceeds: ~$342,116.
- Footnotes of note: the sales were made pursuant to a 10b5-1 trading plan adopted March 13, 2026; some entries reflect multiple trades with weighted-average prices (filing offers to provide trade-level detail on request); certain shares are held in family trusts and the reporting person disclaims beneficial ownership of those except to the extent of pecuniary interest.
- Shares owned after transaction: not specified in the provided filing extract.
- Timeliness: Form 4 was filed on 2026-06-26 covering trades through 2026-06-26, within the typical two-business-day filing window for officers.
Context
- A 10b5-1 trading plan means the sales were executed under a pre-arranged plan, which often indicates pre-scheduled, routine disposals rather than trades made on the basis of current, material nonpublic information.
- Sales by executives are common and do not, by themselves, indicate management sentiment about the company’s outlook.
Insider Transaction Report
Form 4
Duffy Sean P.
DirectorChief Executive Officer
Transactions
- Sale
Common Stock
[F1][F2]2026-06-24$19.01/sh−2,800$53,239→ 409,061 total - Sale
Common Stock
[F1][F3]2026-06-25$19.00/sh−300$5,701→ 408,761 total - Sale
Common Stock
[F1]2026-06-26$19.61/sh−9,844$193,013→ 398,917 total - Sale
Common Stock
[F1]2026-06-26$20.90/sh−4,314$90,163→ 394,603 total
Holdings
- 851,659(indirect: See footnote)
Common Stock
[F4]
Footnotes (4)
- [F1]Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.
- [F2]This transaction was executed in multiple trades at prices ranging from $19.00 to $19.03. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]This transaction was executed in multiple trades at prices ranging from $19.00 to $19.01. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F4]Held in family trusts for the benefit of the Reporting Person's family members. The Reporting Person disclaims beneficial ownership of the shares held by the family trusts except to the extent of his pecuniary interest therein.
Signature
/s/ Nathan Salha, as Attorney-in-Fact for Sean P. Duffy|2026-06-26